<DOC>
	<DOCNO>NCT01848470</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability 3 multiple escalate dose regimen CG400549 administer orally healthy volunteer .</brief_summary>
	<brief_title>Multiple Ascending Doses Study CG400549</brief_title>
	<detailed_description>This Phase 1 , 3 cohort study consist randomise , double-blind , placebo-controlled design .</detailed_description>
	<criteria>Age:1855 year , inclusive Body Mass Index :1930 kg/m2 , inclusive Sex : male Other criterion : healthy ; nonsmoking smoke â‰¤ 10 cigarettes/day Evidence clinically relevant pathology History bacterial viral infection require treatment antibiotic antiviral within 1 month study Presence history esophageal gastroduodenal ulceration within 1 month screening .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>